Advertisement

Quality of Life in Radiation Oncology of Lung Cancer

  • Hans Langendijk
  • Neil Aaronson
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)

Keywords

Radiat Oncol Biol Phys Prophylactic Cranial Irradiation Lung Cancer Symptom Scale Rotterdam Symptom Checklist Endobronchial Brachytherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson NK (1991) Methodological issues in assessing the quality of life of cancer patients. Cancer 67[Suppl]:844–850PubMedGoogle Scholar
  2. Aaronson NK, Fayers P (2002) Quality of life. In: Souhami RL, Tannock I, Hohenberger P, Horiot JC (eds) Oxford textbook of oncology, 2nd edn. Oxford University Press, Oxford, pp 1061–1078Google Scholar
  3. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376aPubMedGoogle Scholar
  4. Auchter RM, Scholtens D, Adak S, et al (2001) Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593.Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 50:1199–206CrossRefPubMedGoogle Scholar
  5. Bailey AJ, Parmar MK, Stephens RJ (1998) Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee. J Clin Oncol. 16:3082–93PubMedGoogle Scholar
  6. Beitz J, Gnecco C, Justice R (1996) Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr 20:7–9PubMedGoogle Scholar
  7. Bergman B, Aaronson NK, Ahmedzai S et al (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials in oncology. Eur J Cancer 30A:635–642CrossRefPubMedGoogle Scholar
  8. Bergner M, Bobbitt RA, Kressel S et al (1976) The Sickness Impact Profile: conceptual foundation and methodology for the development of a health status measure. Int J Health Serv 6: 393–415PubMedGoogle Scholar
  9. Bezjak A, Dixon P, Brundage M, et al (2002) Clinical Trials Group of the National Cancer Institute of Canada. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys. 54:719–728CrossRefPubMedGoogle Scholar
  10. Bleehen NM et al (1991) Inoperable non-small lung cancer (NSCLC): a Medical Research Council randomized trial of palliative radiotherapy with two fractions or 10 fractions. Br J Cancer 63:265–270PubMedGoogle Scholar
  11. Bleehen NM et al (1992) A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions or single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 65:934–941PubMedGoogle Scholar
  12. Buxton J, White M, Osoba D (1998) Patients’ experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 7:513–519PubMedGoogle Scholar
  13. Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMedGoogle Scholar
  14. Cella DF, Bonomi AE, Lloyd SR et al (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12:199–220CrossRefPubMedGoogle Scholar
  15. Cella D, Eton DT, Fairclough DL, et al (2002) What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L)Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG)Study 5592. J Clin Epidemiol. 55:285–95PubMedGoogle Scholar
  16. Cough IR et al (1983) Assessment of the quality of life of patients with advanced disease. Eur J Cancer 19:1161–1165Google Scholar
  17. De Haes JCJM, van Knippenberg FCE et al (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 62:1034–1038PubMedGoogle Scholar
  18. Detmar SB, Muller MJ, Schornagel JH et al (2002) A randomized study of the value of health-related quality of life assessments in daily clinical practice. JAMA 288:3027–3034PubMedGoogle Scholar
  19. EuroQol Group (1990) EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 16:199–208Google Scholar
  20. Fairclough DL, Petersen HF, Cella D et al (1998) Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. Stat Med 17:781–796CrossRefPubMedGoogle Scholar
  21. Falk SJ, Girling DJ, White RJ et al (2002) Medical Research Council Lung Cancer Working Party. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ. 325:465CrossRefPubMedGoogle Scholar
  22. Fayers PM, Bleehen NM, Girling DJ et al (1991) Assessment of quality of life in small-cell lung cancer using a daily diary card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer 64:299–306PubMedGoogle Scholar
  23. Ganz PA et al (1989) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer: does chemotherapy make a difference? Cancer 63:1271–1278PubMedGoogle Scholar
  24. Ganz PA, Schag CAC, Lee JJ et al (1992) The CARES: a generic measure of health-related quality of life for patients with cancer. Qual Life Res 1:19–29CrossRefPubMedGoogle Scholar
  25. Gregor A, Cull A, Stephens RJ, et al (1997) Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 33:1752–1758CrossRefPubMedGoogle Scholar
  26. Hahn EA et al (1998) Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions. Stat Med 17:547–559CrossRefPubMedGoogle Scholar
  27. Hollen PJ, Gralla RJ (1996) Comparison of instruments for measuring quality of life in patients with lung cancer. Sem Oncol 23[Suppl 5]:31–40Google Scholar
  28. Hollen PJ, Gralla RJ, Kris MG et al (1993) Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptoms Scale (LCSS). Eur J Cancer 29A[Suppl 1]:S51–S58PubMedGoogle Scholar
  29. Hollen PJ, Gralla RJ, Kris MC (1994a) Measurement of quality of life in patients with lung cancer in multicentre trial of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087–2098PubMedGoogle Scholar
  30. Hollen PJ, Gralla RJ, Kris M et al (1994b) Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2:213–222CrossRefPubMedGoogle Scholar
  31. Hunt SM, McEwen J, McKenna SP (1981) The Nottingham Health Profile User's Manual. Galen Research, ManchesterGoogle Scholar
  32. Hutchinson TA, Boyd NF, Feinstein AR (1979). Scientific problems in clinical scales as demonstrated in the Karnofsky index of performance status. J Chron Dis 32:661–666CrossRefPubMedGoogle Scholar
  33. Jansen SJ, Kievit J, Nooij MA et al (2001) Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? Br J Cancer 84:1577–1585CrossRefPubMedGoogle Scholar
  34. Johnson JR and Temple R (1985) Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep. 69:1155–1159PubMedGoogle Scholar
  35. Kaasa S, Mastekaasa A, Naess S (1988a) Quality of life of lung cancer patients in a randomized controlled clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol 27:335–342PubMedGoogle Scholar
  36. Kaasa S, Mastekaasa A, Thorud F (1988b) Toxicity, physical function, and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial: Acta Oncol 27:343–349PubMedGoogle Scholar
  37. Karnofsky DA et al (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205Google Scholar
  38. Langendijk JA, ten Velde GPM, Aaronson NK et al (2000a) Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 47:149–155CrossRefPubMedGoogle Scholar
  39. Langendijk JA, Aaronson NK, ten Velde GPM et al (2000b) Pretreatment quality of life of inoperable non-small cell lung carcinoma patients referred for primary radiotherapy. Acta Oncol 24:949–958Google Scholar
  40. Langendijk JA, Aaronson NK, de Jong JMA et al (2001a) Prospective study on quality of life before and after radical radiotherapy in non-small lung cancer. J Clin Oncol 19:2123–2133PubMedGoogle Scholar
  41. Langendijk H, de Jong J, Tjwa M, et al (2001b) External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001; 58:257–268CrossRefGoogle Scholar
  42. Langendijk JA, Aaronson NK, de Jong JMA et al (2002) Quality of life after curative radiotherapy in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 53:847–53CrossRefPubMedGoogle Scholar
  43. Macbeth FR, Bolger JJ, Hopwood P, et al (1996) Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol). 8:167–175Google Scholar
  44. Matthews JNS (1993) A refinement to the analysis of serial data using summary measures. Stat Med 12:27–37PubMedGoogle Scholar
  45. Medical Research Council Lung Cancer Working Party (1996a) Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance. Br J Cancer 73:406–413Google Scholar
  46. Medical Research Council Lung Cancer Working Party (1996b) Randomized trial of four-drug versus less intensive two-drug chemotherapy in the palliative treatment of patients with small cell lung cancer (SCLC) and poor prognosis. Br J Cancer 73:406–413Google Scholar
  47. Michelson H et al (2000) Health-related quality of life measured by the EORTC QLQ-C30: reference values from a large sample of the Swedish population. Acta Oncol 39:477–484CrossRefPubMedGoogle Scholar
  48. Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 48:339–343PubMedGoogle Scholar
  49. Nelson E, Wasson J, Kirk J et al (1987) Assessment of function in routine clinical practice: description of the COOP chart method and preliminary findings. J Chron Dis 40:55S–63SPubMedGoogle Scholar
  50. Nunnaly JC, Bernstein IH (1994) Psychometric therapy. McGraw-Hill, New YorkGoogle Scholar
  51. Osoba D et al (1998) Interpreting the significance of changes in quality of life scores. J Clin Oncol 16:139–144PubMedGoogle Scholar
  52. Presant CA (1984) Quality of life in cancer patients: who measures what? Am J Clin Oncol 7:751–757Google Scholar
  53. Qian W et al (2000) Analysis of messy longitudinal data from a randomized clinical trial. Stat Med 19:2657–2674CrossRefPubMedGoogle Scholar
  54. Ribaudo HJ, Thompson SG (2002) The analysis of repeated multivariate binary quality of life data: a hierarchical model approach. Stat Meth Med Res 11:69–83CrossRefGoogle Scholar
  55. Sadura A et al (1992) Quality of life assessments: patient compliance with questionnaire completion. JNCI 84:1023–1026PubMedGoogle Scholar
  56. Schaafsma J and Coy P (2000) Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 47:691–701CrossRefPubMedGoogle Scholar
  57. Schipper H, Clinch J, McMurray A et al (1984) Measuring the quality of life of cancer patients. The Functional Living Index-Cancer: development and validation. J Clin Oncol 2:472–483PubMedGoogle Scholar
  58. Slevin ML, Plant H, Lynch D et al (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109–112PubMedGoogle Scholar
  59. Speiser BL, Spratling L (1993) Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 25:579–587PubMedGoogle Scholar
  60. Stephens RJ et al (1999) Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise. Br J Cancer 79:538–544CrossRefPubMedGoogle Scholar
  61. Stout R, Barber P, Burt P, et al (2000) Clinical and quality of life outcomes in the first United Kingdom randomised trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol. 56:323–327CrossRefPubMedGoogle Scholar
  62. Velikova G, Booth L, Smith AB et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22:714–724CrossRefPubMedGoogle Scholar
  63. Ware JE, Shelbourne CD (1992) A 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care 30:473–483PubMedGoogle Scholar
  64. Wright EP, Selby PJ, Crawford M et al (2003) Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21:374–382CrossRefPubMedGoogle Scholar
  65. Zee BC (1998) Growth curve model analysis for quality of life data. Stat Med. 17:757–766CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Hans Langendijk
    • 1
  • Neil Aaronson
    • 2
  1. 1.Department of Radiation OncologyVU University Medical CenterAmsterdamThe Netherlands
  2. 2.Division of Psychosocial Research and EpidemiologyThe Netherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations